Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneBio Systems is a private Canadian life science tools and diagnostics company that supplies molecular and cellular biology reagents, consumables, instruments, and custom services to academic, clinical, teaching, and government laboratories. The company markets a large catalog of laboratory products spanning PCR, next-generation sequencing, nucleic acid isolation, cloning, immunoprecipitation, Western blotting, cell culture, ELISA, custom proteins, and custom antibodies. In addition to its distribution business, GeneBio Systems has described proprietary molecular diagnostics technology, including its DASL Rapid platform, aimed at helping clinical laboratories detect infectious diseases. The company appears to operate primarily as a commercial supplier rather than a therapeutics developer, with activity centered on research-use products, diagnostic development, and laboratory support services. It has been active in Canada since 2011 and has indicated reach into the United States and Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GeneBio Systems.